W. R. Berkley Corporation (WRB)
Quantitative Summary
DeterministicWRB trades at 13.5x earnings, roughly in line with its sector average of 19.2x. Financial health is average: Piotroski 5/9, Altman Z 1.4. DCF fair value of $138 implies 106% upside from current prices based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of W. R. Berkley Corporation present a distinct dichotomy between current capital efficiency and historical profitability drivers. The negative ROIC-WACC spread of -2.4% indicates that the company is currently generating returns below its cost of capital, suggesting potential value erosion in recent operational cycles or asset allocation decisions. However, this inefficiency contrasts sharply with an elevated DuPont-decomposed ROE of 18.3%, which is primarily leveraged by a high equity multiplier of 4.54x rather than superior margin expansion or asset turnover, as the net margin sits at 12.2% and turnover remains modest at 0.33x. Risk assessment metrics further complicate the picture; while the Piotroski F-Score of 5/9 suggests moderate financial strength with recent improvements in profitability or leverage management, an Altman Z-Score of 1.4 flags a heightened probability of distress relative to typical solvency norms for the sector.
Valuation dynamics reveal significant divergence between market pricing and intrinsic value models derived from cash flow projections. Trading at a P/E multiple of 14.8x versus a sector average of 18.0x, the stock appears discounted on an earnings basis, yet this compression aligns with a negative ten-year free cash flow growth rate of -4.0% utilized in the DCF model. Despite these headwinds regarding future expansion, the resulting fair value estimate implies substantial upside potential relative to current levels. This valuation gap exists even as profitability factors show neutrality (RMW: -0.098), suggesting that the market may be pricing in sustained stagnation rather than anticipating a turnaround in margin or efficiency improvements.
Risk-adjusted performance metrics and insider behavior provide additional context for the investment thesis, though they do not resolve the fundamental tension between solvency concerns and valuation attractiveness. The stock exhibits a positive Fama-French alpha of 3.62% annually, indicating it has historically outperformed its risk factors despite holding a value tilt (HML: 0.610). Most notably, insider activity over the past ninety days shows net buying totaling approximately $560 million, which may signal management confidence in future operational execution or capital structure optimization. Ultimately, the data presents a scenario where deep valuation discounts and significant insider accumulation coexist with negative long-term growth assumptions and elevated distress risk metrics.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 7% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 6% | 7.6% | 9.6% |
|---|---|---|---|
| 2% | $165 | $117 | $85 |
| 3% | $214 | $138 | $95 |
| 4% | $311 | $172 | $109 |
Center = base case. Green = >10% upside, Red = >10% downside vs $65.18.
Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $138 (+106.4%). Not investment advice.
Valuation Context
Currently trading 50% below its 5-year average P/E of 29.5x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedWRB is trading below both its 50-day and 200-day simple moving averages, suggesting a technical downturn in the short term despite being within an overall bearish trend indicated by these longer-term metrics. The RSI at 40.9 indicates that the stock may be approaching oversold territory, which could signal a potential rebound if positive news breaks or market sentiment shifts favorably.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-02-23 | $0.0900 | -91.7% |
| 2025-12-15 | $1.0900 | +1111.1% |
| 2025-09-22 | $0.0900 | -84.7% |
| 2025-06-23 | $0.5900 | +637.5% |
| 2025-03-03 | $0.0800 | -86.2% |
| 2024-12-16 | $0.5800 | +75.8% |
| 2024-09-23 | $0.3300 | -20.2% |
| 2024-06-24 | $0.4133 | +463.6% |
| 2024-03-01 | $0.0733 | -82.0% |
| 2023-12-15 | $0.4067 | 0.0% |
| 2023-09-22 | $0.4067 | +454.5% |
| 2023-06-23 | $0.0733 | +10.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like KIE or VOE, the fund manager is mechanically forced to buy or sell WRB shares regardless of W. R. Berkley Corporation's individual fundamentals. We estimate $3.0B of passive capital is structurally linked to WRB through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in W. R. Berkley Corporation to visualize passive redemption contagion across ETFs and collateral stocks.
If W. R. Berkley Corporation (WRB) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies BERKSHIRE HATHAWAY INC CL B (BRK.B) as the most exposed collateral stock, sharing 1 ETFs with WRB. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 33 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
WRB Ownership Dynamics
Passive funds hold 1 in every 8 WRB shares, reducing daily market volatility.
W. R. Berkley Corporation (WRB) exerts measurable gravity on the passive index market, currently representing 1.8% of the KIE (KIE) and 0.3% of the VOE (VOE). Across 33 tracked ETFs, approximately 47M shares (12.5% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest WRB Exposure
Float lock-up computed from 33 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
WRB Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for W. R. Berkley Corporation over the past year sits near $70.62 (11% of 252-day volume). The current price of $65.18 sits 7.7% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
WRB Capital Efficiency
How efficiently does W. R. Berkley Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
W. R. Berkley Corporation converts 145% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-3.3%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 2,381 | $65.43 | $155,788.83 |
| 2026-05-13 | 8 | $66.56 | $532.48 |
| 2026-05-11 | 252 | $65.68 | $16,551.36 |
| 2026-04-30 | 183 | $66.95 | $12,251.85 |
| 2026-04-29 | 35 | $67.12 | $2,349.2 |
| 2026-04-28 | 6,298 | $66.20 | $416,927.6 |
| 2026-04-24 | 1,602 | $68.45 | $109,656.9 |
| 2026-04-22 | 26,837 | $65.40 | $1.8M |
| 2026-04-17 | 1,707 | $66.27 | $113,122.89 |
| 2026-04-15 | 2,990 | $65.99 | $197,310.1 |
| 2026-04-14 | 3,507 | $66.96 | $234,828.72 |
| 2026-04-10 | 1,900 | $67.21 | $127,699 |
| 2026-04-09 | 673 | $67.22 | $45,239.06 |
| 2026-04-06 | 23 | $65.99 | $1,517.77 |
| 2026-04-02 | 143 | $65.28 | $9,335.04 |
| 2026-03-31 | 516 | $66.25 | $34,185 |
| 2026-03-27 | 5,301 | $65.26 | $345,943.26 |
| 2026-03-26 | 11,944 | $64.49 | $770,268.56 |
| 2026-03-25 | 30 | $65.03 | $1,950.9 |
| 2026-03-24 | 3,062 | $65.55 | $200,714.1 |
| 2026-03-23 | 6,588 | $65.74 | $433,095.12 |
| 2026-03-19 | 116 | $67.26 | $7,802.16 |
| 2026-03-18 | 696 | $68.85 | $47,919.6 |
| 2026-03-17 | 13,921 | $68.53 | $954,006.13 |
| 2026-03-16 | 355 | $68.76 | $24,409.8 |
| 2026-03-12 | 277 | $67.86 | $18,797.22 |
| 2026-03-11 | 1,512 | $67.86 | $102,604.32 |
| 2026-03-10 | 1,468 | $68.24 | $100,176.32 |
| 2026-03-09 | 657 | $69.92 | $45,937.44 |
| 2026-03-03 | 213 | $73.24 | $15,600.12 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| HIG | 0.719 | 0.651 | High co-movement |
| L | 0.702 | 0.656 | High co-movement |
| TRV | 0.694 | 0.628 | Moderate |
| CB | 0.668 | 0.613 | Moderate |
| ACGL | 0.642 | 0.593 | Moderate |
| CINF | 0.624 | 0.565 | Moderate |
| ALL | 0.616 | 0.564 | Moderate |
| AFL | 0.599 | 0.523 | Moderate |
| PGR | 0.580 | 0.524 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare WRB to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.